Carl A. Pelzel
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Carl A. Pelzel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.
20
| Extinct | Medical Specialties | 20 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.
18
| Extinct | Pharmaceuticals: Major | 18 |
Invenux, Inc.
1
| Extinct | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Carl A. Pelzel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Graduate Degree Masters Business Admin | |
| AFFYMAX, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
| FIBROGEN, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Guangxi University | College/University | Undergraduate Degree | |
| ARRAY TECHNOLOGIES, INC. | Semiconductors | Comptroller/Controller/Auditor | |
VoloAgri Group, Inc.
 VoloAgri Group, Inc. Agricultural Commodities/MillingProcess Industries VoloAgri Group, Inc. offers plant breeding and plant genetics services. The company was founded by Anthony D. Padgett in 2012 and is headquartered in South San Francisco, CA. | Agricultural Commodities/Milling | Director of Finance/CFO | |
| Golden Gate University | College/University | Masters Business Admin | |
| SALESFORCE.COM, INC. | Packaged Software | Comptroller/Controller/Auditor | |
| University of Louisville | College/University | Doctorate Degree | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Idis Ltd.
 Idis Ltd. Drugstore ChainsRetail Trade Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom | Drugstore Chains | Corporate Officer/Principal | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Pharminox Ltd
 Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Medical/Nursing Services | President | |
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Sheffield | College/University | Undergraduate Degree | |
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Melanoma Therapeutics Foundation
 Melanoma Therapeutics Foundation Miscellaneous Commercial ServicesCommercial Services Melanoma Therapeutics Foundation supports and researches treatments for melanoma. It provides resources for patients and physicians, supports investigators, and provides new drug development through bridging relationships between academia, pharmaceutical and biotechnology companies. The foundation is headquartered in San Francisco, California | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Chief Executive Officer | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Kansas State University | College/University | Doctorate Degree | |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| University of Wyoming | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 39 |
| Vereinigtes Königreich | 8 |
| China | 2 |
| Cayman Islands | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 108 |
| Corporate Officer/Principal | 85 |
| Independent Dir/Board Member | 38 |
| Undergraduate Degree | 32 |
| Chief Tech/Sci/R&D Officer | 31 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Lawrence | 29 |
| Hans Bishop | 24 |
| Karen Dawes | 22 |
| Gerry Proehl | 19 |
| Andrew Allen | 18 |
| Sarah Noonberg | 17 |
| Sylvia R. Wheeler | 14 |
| Michael Patrick Smith | 13 |
| John Hamilton | 13 |
| Kristin Anne Torres Mowat | 12 |
| Barbara Klencke | 12 |
| James Schoeneck | 12 |
| Susan E. Barrowcliffe | 11 |
| Anne-Marie S. Duliege | 11 |
| Bruce Eaton | 10 |
- Börse
- Insiders
- Carl A. Pelzel
- Unternehmensverbindungen
